Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 2
2006 1
2008 1
2009 4
2010 1
2011 2
2013 2
2014 3
2015 2
2016 2
2019 2
2020 5
2021 7
2022 2
2023 7
2024 2

Text availability

Article attribute

Article type

Publication date

Search Results

39 results

Results by year

Filters applied: . Clear all
Page 1
Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease.
Zeiser R, Polverelli N, Ram R, Hashmi SK, Chakraverty R, Middeke JM, Musso M, Giebel S, Uzay A, Langmuir P, Hollaender N, Gowda M, Stefanelli T, Lee SJ, Teshima T, Locatelli F; REACH3 Investigators. Zeiser R, et al. N Engl J Med. 2021 Jul 15;385(3):228-238. doi: 10.1056/NEJMoa2033122. N Engl J Med. 2021. PMID: 34260836 Clinical Trial.
Addition of isatuximab to lenalidomide, bortezomib, and dexamethasone as induction therapy for newly diagnosed, transplantation-eligible patients with multiple myeloma (GMMG-HD7): part 1 of an open-label, multicentre, randomised, active-controlled, phase 3 trial.
Goldschmidt H, Mai EK, Bertsch U, Fenk R, Nievergall E, Tichy D, Besemer B, Dürig J, Schroers R, von Metzler I, Hänel M, Mann C, Asemissen AM, Heilmeier B, Weinhold N, Huhn S, Kriegsmann K, Luntz SP, Holderried TAW, Trautmann-Grill K, Gezer D, Klaiber-Hakimi M, Müller M, Khandanpour C, Knauf W, Scheid C, Munder M, Geer T, Riesenberg H, Thomalla J, Hoffmann M, Raab MS, Salwender HJ, Weisel KC; German-Speaking Myeloma Multicenter Group (GMMG) HD7 investigators. Goldschmidt H, et al. Among authors: holderried taw. Lancet Haematol. 2022 Nov;9(11):e810-e821. doi: 10.1016/S2352-3026(22)00263-0. Lancet Haematol. 2022. PMID: 36328040 Clinical Trial.
ROCKing Chronic Graft-Versus-Host Disease.
Heine A, Holderried TAW, Wolf D. Heine A, et al. Among authors: holderried taw. J Clin Oncol. 2021 Oct 10;39(29):3308. doi: 10.1200/JCO.21.01081. Epub 2021 Aug 4. J Clin Oncol. 2021. PMID: 34347530 No abstract available.
NK Cells Regulate CD8+ T Cell Mediated Autoimmunity.
Lang PA, Crome SQ, Xu HC, Lang KS, Chapatte L, Deenick EK, Grusdat M, Pandyra AA, Pozdeev VI, Wang R, Holderried TAW, Cantor H, Diefenbach A, Elford AR, McIlwain DR, Recher M, Häussinger D, Mak TW, Ohashi PS. Lang PA, et al. Among authors: holderried taw. Front Cell Infect Microbiol. 2020 Feb 13;10:36. doi: 10.3389/fcimb.2020.00036. eCollection 2020. Front Cell Infect Microbiol. 2020. PMID: 32117809 Free PMC article.
The Role of Immune Checkpoints after Cellular Therapy.
Schmitz F, Wolf D, Holderried TAW. Schmitz F, et al. Among authors: holderried taw. Int J Mol Sci. 2020 May 21;21(10):3650. doi: 10.3390/ijms21103650. Int J Mol Sci. 2020. PMID: 32455836 Free PMC article. Review.
Immunomodulatory effects of anti-angiogenic drugs.
Heine A, Held SA, Bringmann A, Holderried TA, Brossart P. Heine A, et al. Among authors: holderried ta. Leukemia. 2011 Jun;25(6):899-905. doi: 10.1038/leu.2011.24. Epub 2011 Feb 25. Leukemia. 2011. PMID: 21350557 Review.
Immunotherapy in renal cell carcinoma.
Heine A, Holderried TA, Brossart P. Heine A, et al. Among authors: holderried ta. Immunotherapy. 2009 Jan;1(1):97-107. doi: 10.2217/1750743X.1.1.97. Immunotherapy. 2009. PMID: 20635977 Review.
Innate response activator B cells aggravate atherosclerosis by stimulating T helper-1 adaptive immunity.
Hilgendorf I, Theurl I, Gerhardt LM, Robbins CS, Weber GF, Gonen A, Iwamoto Y, Degousee N, Holderried TA, Winter C, Zirlik A, Lin HY, Sukhova GK, Butany J, Rubin BB, Witztum JL, Libby P, Nahrendorf M, Weissleder R, Swirski FK. Hilgendorf I, et al. Among authors: holderried ta. Circulation. 2014 Apr 22;129(16):1677-87. doi: 10.1161/CIRCULATIONAHA.113.006381. Epub 2014 Jan 31. Circulation. 2014. PMID: 24488984 Free PMC article.
39 results